
Core Laboratories Inc. (NYSE:CLB – Free Report) – Investment analysts at Zacks Research cut their FY2026 earnings estimates for Core Laboratories in a research report issued on Wednesday, November 18th. Zacks Research analyst Team now expects that the oil and gas company will post earnings per share of $0.60 for the year, down from their previous forecast of $0.61. The consensus estimate for Core Laboratories’ current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2028 earnings at $0.23 EPS.
Core Laboratories (NYSE:CLB – Get Free Report) last released its earnings results on Wednesday, October 28th. The oil and gas company reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $132.08 million during the quarter, compared to analysts’ expectations of $131.87 million. Core Laboratories had a net margin of 3.42% and a return on equity of 8.94%. The company’s quarterly revenue was down 1.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.22 earnings per share.
View Our Latest Stock Analysis on CLB
Core Laboratories Trading Down 7.8%
CLB stock opened at $7.75 on Thursday. The company has a current ratio of 2.19, a quick ratio of 1.60 and a debt-to-equity ratio of 0.40. Core Laboratories has a 12-month low of $7.71 and a 12-month high of $20.36. The stock has a market cap of $354.88 million, a price-to-earnings ratio of 20.38, a PEG ratio of 1.69 and a beta of 1.18. The business’s 50-day moving average is $9.95 and its 200 day moving average is $13.14.
Hedge Funds Weigh In On Core Laboratories
A number of institutional investors and hedge funds have recently bought and sold shares of CLB. BlackRock Inc. acquired a new stake in shares of Core Laboratories in the 2nd quarter worth $86,910,000. Heartland Advisors Inc. acquired a new position in shares of Core Laboratories during the 2nd quarter valued at about $12,329,000. Bank of New York Mellon Corp acquired a new position in shares of Core Laboratories during the 2nd quarter valued at about $4,675,000. Archon Capital Management LLC grew its holdings in shares of Core Laboratories by 152.1% in the third quarter. Archon Capital Management LLC now owns 450,475 shares of the oil and gas company’s stock valued at $4,370,000 after purchasing an additional 271,775 shares during the period. Finally, Advisors Capital Management LLC purchased a new stake in shares of Core Laboratories in the second quarter valued at about $2,766,000. 97.81% of the stock is currently owned by institutional investors and hedge funds.
Core Laboratories Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Monday, November 9th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Monday, November 9th. Core Laboratories’s dividend payout ratio (DPR) is currently 10.53%.
Core Laboratories Company Profile
Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.
Recommended Stories
- Five stocks we like better than Core Laboratories
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
